ISRCTN75728112已完成不适用
A randomised, placebo-controlled, double-blind trial of ondansetron in renal itch
HS R&D Regional Programme Register - Department of Health (UK)0 个研究点目标入组 25 人开始时间: 2004年1月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Twenty-five patients will be recruited from the renal dialysis unit, only patients on haemodialysis will be included. Patients with a history of pruritus for more than eight weeks will be given a visual analogue scale to assess the severity of pruritus twice a day for one week. Those patients with a mean peak value greater than 5 out of 10 for the last five days of the week will be included.
排除标准
- •Patients will be excluded if they have concomitant dermatological disease associated with pruritus as assessed by a dermatologist (MM) or another metabolic cause of itch.
研究者
相似试验
已完成
2 期
Antidepressant trial of a novel P2X7 receptor blocker JNJ-54175446ISRCTN44411633Cambridgeshire and Peterborough NHS Foundation Trust15
招募中
2 期
A randomised, placebo-controlled, double-blind trial to assess the safety and glucose-lowering efficacy of VVP808 in participants with Type 2 diabetes.ACTRN12609000634279Verva Pharmaceuticals80
进行中（未招募）
1 期
Antidepressant trial of a novel P2X7 receptor blocker JNJ-54175446.Major depressive disorder with an incomplete response to monoaminergic antidepressants and with biomarker profile indicative of inflammationMedDRA version: 21.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSSystem Organ Class: 100000004873EUCTR2018-001884-21-GBCambridgeshire and Peterborough NHS Foundation Trust and University of Cambridge142
进行中（未招募）
1 期
A study to investigate the efficacy and tolerability of the drug ESO-101 in adult patients with inflammation of the esophagusActive eosinophilic esophagitisMedDRA version: 20.1Level: PTClassification code 10064212Term: Eosinophilic oesophagitisSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2020-000082-16-PLEsoCap AG42
进行中（未招募）
4 期
Can treatment with Cerebrolysin improve recovery after acute ischemic stroke?Radiologically confirmed acute ischemic stroke with onset within 72 hours prior to screeningCirculatory SystemAcute ischemic strokeISRCTN88122184The foundation for the study of neuroscience and neuroregeneration290